AI assistant
Sending…
Coloplast — Director's Dealing 2019
Aug 14, 2019
3358_rns_2019-08-14_e51c3d49-6fc8-4a35-a346-2550fd9aa011.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Nasdaq Copenhagen
14 August 2019
Coloplast A/S
Holtedam 1
3050 Humlebaek
Denmark
Tel: +45 4911 1111
www.coloplast.com
CVR-nr. 69749917
Report on transactions of executives and related parties in Coloplast shares and related securities
According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transaction concerns the sale share.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
|---|---|---|---|
| a) | Name | Jørgen Tang-jensen | |
| 2 | Reason for the notification | ||
| a) | Position/status | Member of the Board of Directors | |
| b) | Initial notification/Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Coloplast A/S (CVR-no.: 69749917) | |
| b) | LEI | 529900NN7SQJ5QG82X67 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | ||
| Identification code | B shares | ||
| ISIN: DK0060448595 | |||
| b) | Nature of the transaction | Sale of shares | |
| c) | Price(s) and volume(s) | Price(s) | Volumes(s) |
| 817.20 | 8 | ||
| 817.00 | 22 | ||
| 816.80 | 60 | ||
| 816.40 | 46 | ||
| 815.60 | 90 | ||
| 815.60 | 49 | ||
| 815.80 | 45 | ||
| 815.40 | 100 | ||
| 815.60 | 58 | ||
| 815.60 | 75 | ||
| 816.00 | 37 | ||
| 816.00 | 75 |
This information is available in Danish and in English, in case of doubt the Danish version prevails. For further information: Anne-Sofie Søegaard, tel.: +45 4911 1924
Coloplast
Ostomy Care
Continence Care
Wound & Skin Care
Urology Care
| 816.40 | 75 | ||
|---|---|---|---|
| 816.60 | 60 | ||
| 816.60 | 100 | ||
| 816.80 | 31 | ||
| 816.80 | 75 | ||
| 817.00 | 32 | ||
| 817.20 | 22 | ||
| 817.20 | 33 | ||
| 817.20 | 13 | ||
| 817.20 | 32 | ||
| 817.20 | 75 | ||
| 817.40 | 100 | ||
| 817.60 | 151 | ||
| 815.00 | 41 | ||
| 815.20 | 200 | ||
| 815.80 | 24 | ||
| 815.80 | 60 | ||
| 815.20 | 200 | ||
| 815.60 | 58 | ||
| 816.20 | 22 | ||
| 816.40 | 58 | ||
| 815.20 | 50 | ||
| 816.80 | 40 | ||
| 815.60 | 31 | ||
| 814.80 | 75 | ||
| 815.00 | 55 | ||
| 815.80 | 75 | ||
| d) | Aggregated information - Aggregated volume - Price | 2,453 shares 816.08 DKK (volume weighted average) | |
| e) | Date of the transaction | 2019-08-14, 13:14 | |
| f) | Place of the transaction | Nasdaq Copenhagen A/S (XCSE) |
More from Coloplast
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23